TABLE 1.
The various strategies to control and minimize the formation of recombinant protein inclusion bodies in E. coli.
| Strategies | Specific approaches | Potential mechanism | Comments | References |
| Tailoring culture conditions | Lowering the culture temperature in induction phase | Reducing protein expression rate | Two-phase culture used. First-phase at 37°C for cell growth, second phase at 15–20°C for the induction of protein expression | Cabilly, 1989; Shirano and Shibata, 1990; Jung et al., 2013; Sina et al., 2015; Carere et al., 2018a; Wang et al., 2019 |
| Introducing a short time heat shock prior to expression induction | To induce chaperons’ production, meanwhile minimize IBs formation | E.g., 47°C for 20–30 min | Oganesyan et al., 2007 | |
| Decreasing the concentration of inducer (e.g., IPTG) | Reducing protein expression rate | E.g., 0.01–0.05 mM instead of 0.5–1.0 mM | Jhamb and Sahoo, 2012; Sina et al., 2015 | |
| Adding glucose in growth medium | Reducing protein expression rate through catabolic repression effect of glucose to the induction | The glucose concentration at 1–2% was often used | Grossman et al., 1998 | |
| Adding chemical additives (e.g., D-sorbitol, glycerol, ethanol, NaCl et al) | Sorbitol, glycerol and NaCl will cause osmotic stress and further induce osmolytes synthesis or uptake. Ethanol will elicit heat shock response and induce the production of chaperones | Often used conditions: Sorbitol (0.5–1.0 M), NaCl (0.2–0.8 M), Betaine (1 mM), Ethanol [3% (v/v)] | Blackwell and Horgan, 1991; Diamant et al., 2001; Oganesyan et al., 2007 | |
| Adding co-factors of target protein in growth medium | To assist proper protein folding | Many proteins require cofactors for their proper folding such as metalloenzymes | Bushmarina et al., 2006; Rosano and Ceccarelli, 2014 | |
| Use buffer to control pH of growth medium | Controlling the pH fluctuation for the proper protonation states of proteins | No fluctuations to the protein, keeps it chemically stable | Castellanos-Mendoza et al., 2014 | |
| Expression host engineering | Engineered strains to catalyze di-sulfide bond formation—TrxB, gor mutants, CyDisCo system | Trxb– and gor– generate a more oxidizing environment. CyDisCo involves di-sulfide bonds catalyzed by a sulfhydryl oxidase Erv1p | Proteins requiring di-sulfide bonds can be successfully folded and functional. E.g., SHuffle and Origami strains, CyDisCo system | Xiong et al., 2005; Rasiah and Rehm, 2009; Nguyen et al., 2011; Lobstein et al., 2012; Hatahet and Ruddock, 2013 |
| Engineering strains to perform glycosylation | Addition of enzymes or pathways able to catalyze N- or O-linked glycosylation Knockouts of wecA and waaL to remove competing glycan pathways | Important implications for activity, structure, and stability E.g., CLM37 and CLM24 strains | Wacker et al., 2002; Feldman et al., 2005 | |
| Co-expressing chaperone | Aid in the proper protein folding | E.g., GroEL, GroES, ClpB | Lee et al., 2004; de Marco et al., 2007; Jhamb and Sahoo, 2012 | |
| Co-expressing foldase | Aid in the proper protein folding and disulfide bond formation | Include protein disulfide isomerases (PDI) and peptidyl prolyl isomerases (PPI) | Ngiam et al., 2000; Lee et al., 2004; Jung et al., 2013; Zhuo et al., 2014 | |
| Strains engineered for membrane proteins or toxic proteins | Dampening of T7 RNA polymerase expression and/or activity | Aims to reduce expression levels to reduce toxicity and improve membrane protein expression E.g., E. coli strains C41 (DE3), C43 (DE3), Lemo21 (DE3), BL21 (DE3) pLysS, pAVEwayTM | Miroux and Walker, 1996; Wagner et al., 2008; Kwon et al., 2015; Kim et al., 2017 | |
| Co-expressing multiple components of protein complex | The co-expression of protein components is beneficial for protein folding, stability and protect individual components from degradation | Using compatible duet vectors with different antibiotics resistance | Tolia and Joshua-Tor, 2006 | |
| Engineered metal ion transport for metalloenzymes | Overexpress operons involved in uptake/transport of metal cofactors | Overexpressing cobalamin transport pathways and Suf pathways shown to produce proteins with full iron occupancy | Lanz et al., 2018; Corless et al., 2020 | |
| Use weaker promotor | Reducing protein expression rate | Better balance between protein synthesis and folding, and lower metabolic burden to host cells | Kaur et al., 2018 | |
| Linked to a soluble fusion tag or chaperone at either N- or C-terminus. | Improve protein expression yields, solubility and folding, facilitate protein purification. | E.g., maltose binding protein, glutathione-S-transferase, Spy | Vu et al., 2014; Ruan et al., 2020 | |
| Altering expression vector | Plasmid display technology, linking the target protein to a DBD | Target protein and DBD are attached to the plasmid itself, aids in stabilization | Ensure a soluble DBD partner E.g., Oct-1 DBD, GAL4 DBD | Xiong et al., 2005; Park et al., 2013, 2020 |
| Use a low copy number plasmid | Reducing protein expression rate | Better balance between protein synthesis and folding, and lower metabolic burden to host | Kaur et al., 2018 | |
| Minimize the hydrophobic patch on the surface of protein | Site directed mutagenesis to change aggregation-promoting residues | Prediction using programs Ex. TANGO, PASTA 2.0, AMYLPRED 2.0, Protein-Sol, SoDoPE | Conchillo-Solé et al., 2007; Tsolis et al., 2013; Walsh et al., 2014; Hebditch et al., 2017; Bhandari et al., 2020 | |
| Express partial protein (truncated and soluble domain) | Potential aggregation prone protein is expressed in a soluble state | Based on the purpose for the protein, as it may not be functional | Chen et al., 2003 | |
| Modifying the protein of interest | Add signal peptide to direct the expressed protein into periplasmic area | It is beneficial for folding with the more oxidized environment and foldases in the periplasmic space | Less proteolytic activity in periplasmic space | Dow et al., 2015; Malik, 2016 |